The blending effect of natural polysaccharides with nano-zirconia towards the removal of fluoride and arsenate from water

Nano-zirconia (ZO) was synthesized using a microwave-assisted one-pot precipitation route. Two biopolymers, chitosan (CTS) and carboxymethyl cellulose were blended with ZO at different w/w ratios. The formulation with 30% w/w chitosan (ZO-CTS) was found to give enhanced uptake of F− and As(V). ZO and the most effective ZO-CTS system were characterized using Fourier transform infrared spectroscopy, scanning electron microscopy, X-ray diffraction and X-ray photoelectron spectroscopy. These confirmed the formation of a composite system containing nanoparticles of 50 nm in size, in which ZO was present in the amorphous form. It was observed that the combination of ZO with CTS improved the F− and As(V) adsorption capacity most notably at pH 5.5. Fluoride adsorption by ZO-CTS followed the Freundlich isotherm model, with an adsorption capacity of 120 mg g−1. Adsorption of As(V) by ZO-CTS could be fitted with both the Langmuir and Freundlich isotherm models and was found to have a capacity of 14.8 mg g−1. Gravity filtration studies conducted for groundwater levels indicated the effectiveness of ZO-CTS in adsorbing As(V) and F− at a pH of 5.5. The ability of the ZO-CTS in removing Cd(II) and Pb(II) was also investigated, and no such enhancement was observed, and found the neat ZO was the most potent sorbent here

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

Breast cancer is a common disease partially caused by genetic risk factors. Germline pathogenic variants in DNA repair genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 are associated with breast cancer risk. FANCM, which encodes for a DNA translocase, has been proposed as a breast cancer predisposition gene, with greater effects for the ER-negative and triple-negative breast cancer (TNBC) subtypes. We tested the three recurrent protein-truncating variants FANCM:p.Arg658*, p.Gln1701*, and p.Arg1931* for association with breast cancer risk in 67,112 cases, 53,766 controls, and 26,662 carriers of pathogenic variants of BRCA1 or BRCA2. These three variants were also studied functionally by measuring survival and chromosome fragility in FANCM -/- patient-derived immortalized fibroblasts treated with diepoxybutane or olaparib. We observed that FANCM:p.Arg658* was associated with increased risk of ER-negative disease and TNBC (OR = 2.44, P = 0.034 and OR = 3.79; P = 0.009, respectively). In a country-restricted analysis, we confirmed the associations detected for FANCM:p.Arg658* and found that also FANCM:p.Arg1931* was associated with ER-negative breast cancer risk (OR = 1.96; P = 0.006). The functional results indicated that all three variants were deleterious affecting cell survival and chromosome stability with FANCM:p.Arg658* causing more severe phenotypes. In conclusion, we confirmed that the two rare FANCM deleterious variants p.Arg658* and p.Arg1931* are risk factors for ER-negative and TNBC subtypes. Overall our data suggest that the effect of truncating variants on breast cancer risk may depend on their position in the gene. Cell sensitivity to olaparib exposure, identifies a possible therapeutic option to treat FANCM-associated tumors

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

Abstract: Breast cancer is a common disease partially caused by genetic risk factors. Germline pathogenic variants in DNA repair genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 are associated with breast cancer risk. FANCM, which encodes for a DNA translocase, has been proposed as a breast cancer predisposition gene, with greater effects for the ER-negative and triple-negative breast cancer (TNBC) subtypes. We tested the three recurrent protein-truncating variants FANCM:p.Arg658*, p.Gln1701*, and p.Arg1931* for association with breast cancer risk in 67,112 cases, 53,766 controls, and 26,662 carriers of pathogenic variants of BRCA1 or BRCA2. These three variants were also studied functionally by measuring survival and chromosome fragility in FANCM−/− patient-derived immortalized fibroblasts treated with diepoxybutane or olaparib. We observed that FANCM:p.Arg658* was associated with increased risk of ER-negative disease and TNBC (OR = 2.44, P = 0.034 and OR = 3.79; P = 0.009, respectively). In a country-restricted analysis, we confirmed the associations detected for FANCM:p.Arg658* and found that also FANCM:p.Arg1931* was associated with ER-negative breast cancer risk (OR = 1.96; P = 0.006). The functional results indicated that all three variants were deleterious affecting cell survival and chromosome stability with FANCM:p.Arg658* causing more severe phenotypes. In conclusion, we confirmed that the two rare FANCM deleterious variants p.Arg658* and p.Arg1931* are risk factors for ER-negative and TNBC subtypes. Overall our data suggest that the effect of truncating variants on breast cancer risk may depend on their position in the gene. Cell sensitivity to olaparib exposure, identifies a possible therapeutic option to treat FANCM-associated tumors

The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance : an AMR Insights global perspective

The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic’s potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pathogens, requiring the extensive use of antibiotics. However, antibiotics may also be inappropriately used in milder cases of COVID-19 infection. Further, concerns such as increased biocide use, antimicrobial stewardship/infection control, AMR awareness, the need for diagnostics (including rapid and point-of-care diagnostics) and the usefulness of vaccination could all be components shaping the influence of the COVID-19 pandemic. In this publication, the authors present a brief overview of the COVID-19 pandemic and associated issues that could influence the pandemic’s effect on global AMR.This study was supported by internal funding.https://academic.oup.com/jacamram2022School of Health Systems and Public Health (SHSPH

Comparision of traditional and laboratory methods of sulphur processing

Background: Since ancient times, the essential element sulphur has played an important role in different medical fields. It is one of the main materials used in herbo-mineral pharmaceutics in Ayurveda. However, for Ayurvedic pharmaceutical preparations, the purity of sulphur is crucial in avoiding any harmful reactions and to enhance the medicinal quality. Therefore, it is subjected to a process called ‘gandhaka shodhana’ using cow's milk, ghee or occasionally plant extracts. The plant, Eclipta alba (L.) Hassak, containing many bioactive compounds, is one of the extracts known to be used in the ‘shodhana’ process of sulphur. However, in comparison to the laboratory purification method of sulphur neither the effect of this ‘shodhana’ process in removing impurities from sulphur nor its effect on the structure and morphology of sulphur has been evaluated. Objectives: This study identifies physical, morphological, and structural changes that occur in sulphur when it is subjected to the ‘shodhana’ process compared to the changes that occur in sulphur obtained after simple laboratory purification. Methodology: Both samples were characterized using Scanning Electron Microscopy, Energy Dispersive X-ray Spectroscopy, X-ray Diffraction, Differential Scanning Calorimetry, Thermogravimetric Analysis, Fourier Transform Infrared spectroscopy, and Raman spectroscopy. Observed physical changes such as colour, allotropic form, odour, hardness, transparency, and lustre of the samples were also determined using recommended techniques. Results: Although the laboratory purification method separates the sulphur from physical and chemical impurities, Ayurveda ‘shodhana’ process with E. alba converts the sulphur into a more pharmaceutically suitable form by making it more nebulous and introducing higher brittleness, FT-IR data shows removal of chemical impurities from sulphur during ‘shodhana’ process in contrast to laboratory purified sample

Development of graphene oxide-based polypyrrole nanocomposite for effective removal of anionic and cationic dyes from water

The majority of toxins, including metal ions, organic wastes, particularly dyes, and other inorganic wastes, are released into the environment today as a main problem of increased industry. These pollutants primarily disrupt the balance of the environment and harm people's health. In this work, attempts were taken to develop a graphene oxide-based nanocomposite with polypyrrole (GO/PP) as a versatile adsorbent. Initially, GO/PP nanocomposites were prepared with different GO/PP ratios, and initial adsorption studies were conducted towards organic dyes, lead ions, cadmium ions, and fluoride ions to identify the best ratio. GO/PP with a 20:80 ratio was identified as the most efficient adsorbent out of all the prepared materials. This material was characterized to identify its crystallinity, morphology, functional groups, and thermal properties using the X-ray diffractometer (XRD) technique, Scanning electron microscope (SEM), Fourier Transform Infrared (FTIR), UV–visible spectrometer, and Raman spectroscopy. In this work, we report the adsorption properties of cationic rhodamine B (RhB) and anionic methyl orange (MeO) towards GO/PP 20:80 nanocomposites. The best-fitted kinetic model for both dyes was the pseudo-second-order model. The calculated dye removal efficiency for MeO and RhB was 98.40% and 99.90% within a contact time of 30 min and 10 min respectively at optimum pH of 7. The best-fitted isotherm model for RhB was the Freundlich model with 10.52 mg g−1 and the best-fitted isotherm model for MeO was the Langmuir model with 9.61 mg g−1 maximum adsorption capacities. The studies indicated that GO/PP can be used in gravity filtration and can effectively be regenerated

Role of Nanotechnology in Diagnosing, Safeguarding, and Treating COVID-19 : Role of Nanotechnology in Diagnosing, Safeguarding, and Treating COVID-19

Coronavirus disease (COVID-19) is arguably the worst health crisis the world has faced in the 21st century, and the World Health Organization declared this a “public health emergency of international concern” during the beginning of the pandemic and continued for a significant period of time.  Considering the public health risk and the delay in introducing  a suitable medical intervention to eradicate this virus, many reserachers embarked on different technologies to develop a cure. Nanotechnology has emerged as a promising weapon in the fight against COVID-19 and other similar viral diseases. The unique qualities of nanomaterials make them excellent for a variety of applications, including the development of low-cost, real-time diagnostic systems, reusable personal protective equipment, and innovative carriers for biological cargo such as mRNA in vaccines and CRISPR/Cas9 in gene editing. In this review the current available pharmacological and non-pharmacological options that are being used around the world against COVID-19 are compared with their nanotechnological counterparts. Here, we also elaborate the advantages of currently available nanotechnology-based diagnostics, protective equipment, vaccines and therapeutics and discuss future directions and steps that should be taken to translate these technologies into a clinical setting to combat the COVID-19 pandemic

Nanosilver Rainbow: A Rapid and Facile Method to Tune Different Colours of Nanosilver Through the Controlled Synthesis of Stable Spherical Silver Nanoparticles

A rapid and simple one-pot reaction to synthesize stable, spherically shaped silver nanoparticles (AgNps) of different sizes producing distinct optical properties in aqueous solution at ambient temperature has been developed. Each system contains various sizes of silver nanoparticles showing rainbow colours with the peak wavelength of the absorption spectra ranging from 400 to 750 nm. Seven different colours of nano silver were developed through the controlled synthesis of spherical silver nanoparticles using silver nitrate as the metal precursor. Sodium borohydride was used as the main reducing agent and trisodium citrate and hydrazine sulphate were used as the stabilizing and auxiliary reducing agents respectively. The colour of the solution was controlled by varying the concentrations of reagents and the optimum conditions for all the colours are reported. Characterization of silver nanoparticles was carried out using UV-visible spectrophotometry and Transmission Electron Microscopy (TEM). Factors affecting the formation of different sizes of silver nanoparticles, such as silver nitrate concentration, reducing agent concentrations, reaction temperature and reaction pH are also reported. The stability of these coloured silver colloidal solutions was also investigated at different temperatures and the most stable temperature was found to be 4 °C, while the optimum pH to synthesize distinctively coloured silver nanoparticles was found to be in the range of 7–8. The outlined procedure provides a rapid, facile and reproducible synthetic route to spherical AgNps of varying size and ensuing optical properties. Thus, this method is certain to find value in the many applications where size tunability of AgNps is desired

Fabrication of 6-gingerol, doxorubicin and alginate hydroxyapatite into a bio-compatible formulation: enhanced anti-proliferative effect on breast and liver cancer cells

Abstract Ample attention has been devoted to the construction of anti-cancer drug delivery systems with increased stability, and controlled and targeted delivery, minimizing toxic effects. In this study we have designed a magnetically attractive hydroxyapatite (m-HAP) based alginate polymer bound nanocarrier to perform targeted, controlled and pH sensitive drug release of 6-gingerol, doxorubicin, and their combination, preferably at low pH environments (pH 5.3). They have exhibited higher encapsulation efficiency which is in the range of 97.4–98.9% for both 6-gingerol and doxorubicin molecules whereas the co-loading has accounted for a value of 81.87 ± 0.32%. Cell proliferation assays, fluorescence imaging and flow cytometric analysis, demonstrated the remarkable time and dose responsive anti-proliferative effect of drug loaded nanoparticles on MCF-7 cells and HEpG2 cells compared with their neat counter parts. Also, these systems have exhibited significantly reduced toxic effects on non-targeted, non-cancerous cells in contrast to the excellent ability to selectively kill cancerous cells. This study has suggested that this HAP based system is a versatile carrier capable of loading various drug molecules, ultimately producing a profound anti-proliferative effect

Characterization data and Isotherm data from Metal and polymer-mediated synthesis of porous crystalline hydroxyapatite nanocomposites for environmental remediation

Legend for ESM is separately uploaded